QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia

BACKGROUND: Hydroxychloroquine/chloroquine (HCQ/CQ) treatment for COVID‐19 was associated with QT interval prolongation and arrhythmia risks. This study aimed to investigate QTc interval and ventricular repolarization dispersion changes, as markers of arrhythmia risks, after HCQ/CQ administration wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gumilang, Rizki A., Siswanto, Anggraeni, Vita Y., Trisnawati, Ika, Budiono, Eko, Hartopo, Anggoro B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485784/
https://www.ncbi.nlm.nih.gov/pubmed/34621417
http://dx.doi.org/10.1002/joa3.12623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485784/
https://www.ncbi.nlm.nih.gov/pubmed/34621417
http://dx.doi.org/10.1002/joa3.12623

Ejemplares similares